The Cytel Blog: Perspectives on Enquiry & Evidence

While randomized control trials remain the industry gold-standard for regulatory and reimbursement submissions, there..

At ISPOR US 2022, Cytel’s HEOR & RWE experts will be contributing to a range of Issue Panels, In-person Podium..

The Life Sciences landscape has seen an impactful digital evolution in the past two years. The pandemic has accelerated..

Over the past decade, single arm trials have emerged as an accepted way of assessing a new treatment intervention...

After twenty years in pharma, Anna Forsythe was frustrated by traditional vendors who used outdated methods to prepare..

  We continue our series of blogs covering the expert presentations from the EAST User Group Meeting. Consultant Claire..